| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |